GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 328 filers reported holding GW PHARMACEUTICALS PLC in Q2 2019. The put-call ratio across all filers is 1.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,577,000 | -82.5% | 11,881 | -90.7% | 0.17% | -83.9% |
| Q4 2020 | $14,759,000 | +58.8% | 127,885 | +33.9% | 1.05% | +38.9% |
| Q3 2020 | $9,297,000 | -17.8% | 95,499 | +3.6% | 0.75% | -32.5% |
| Q2 2020 | $11,311,000 | +17.1% | 92,169 | -16.5% | 1.12% | +1.0% |
| Q1 2020 | $9,660,000 | -11.9% | 110,317 | +5.2% | 1.11% | -1.9% |
| Q4 2019 | $10,961,000 | +40.1% | 104,834 | +54.1% | 1.13% | +26.1% |
| Q3 2019 | $7,824,000 | -33.0% | 68,019 | +0.5% | 0.89% | -34.6% |
| Q2 2019 | $11,670,000 | +6.5% | 67,695 | +4.1% | 1.37% | +0.1% |
| Q1 2019 | $10,957,000 | +404.9% | 64,998 | +191.7% | 1.36% | +475.9% |
| Q4 2018 | $2,170,000 | -45.5% | 22,282 | -3.3% | 0.24% | -34.5% |
| Q3 2018 | $3,982,000 | +24.3% | 23,054 | +0.4% | 0.36% | +20.7% |
| Q2 2018 | $3,204,000 | – | 22,963 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 3,455,054 | $456,102,000 | 8.18% |
| Consonance Capital Management LP | 675,492 | $89,172,000 | 8.05% |
| Prisma Capital Partners LP | 33,000 | $4,356,000 | 4.11% |
| Broadfin Capital, LLC | 122,930 | $16,228,000 | 2.65% |
| Rock Springs Capital Management LP | 354,000 | $46,732,000 | 2.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 339,180 | $44,775,000 | 1.76% |
| GREAT POINT PARTNERS LLC | 75,000 | $9,901,000 | 1.69% |
| Atika Capital Management LLC | 31,000 | $4,092,000 | 1.58% |
| Sivik Global Healthcare LLC | 30,000 | $3,960,000 | 1.47% |
| Sio Capital Management, LLC | 19,000 | $2,508,000 | 1.41% |